Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination
Language English Country Great Britain, England Media print-electronic
Document type Case Reports, Journal Article
PubMed
21220258
DOI
10.1136/adc.2010.198184
PII: adc.2010.198184
Knihovny.cz E-resources
- MeSH
- Humans MeSH
- Laryngeal Neoplasms * prevention & control surgery virology MeSH
- Follow-Up Studies MeSH
- Papilloma * prevention & control surgery virology MeSH
- Child, Preschool MeSH
- Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 MeSH
- Secondary Prevention MeSH
- Papillomavirus Vaccines * MeSH
- Check Tag
- Humans MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 MeSH
- Papillomavirus Vaccines * MeSH
The authors describe the case of a 5-year-old girl with recurrent laryngeal papillomatosis (RLP) due to human papillomavirus (HPV) type 11, who required frequent surgical treatment. Complete recovery occurred after HPV vaccination (Gardasil). Confirmed remission of RLP has continued during the 17 months of follow-up since vaccination. The authors conclude that HPV vaccination may represent a new therapeutic option in this situation.
References provided by Crossref.org
